Nathan Silberman is the Chief Technology Officer at Artera AI, where he leads the development of machine learning systems that interpret pathology slides and clinical data to personalize cancer therapy. He has built and scaled multiple high-performance AI organizations, previously leading machine learning teams at PathAI, Butterfly Network, and Google, with work spanning gigapixel pathology, real-time ultrasound AI, and FDA-cleared clinical models. His career focuses on translating cutting-edge research into robust, production-grade medical AI platforms that improve diagnostic precision and support better treatment decisions at scale.